List of Subject Classifications Records

Browse Results (71 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

 Browse by Research Fields, Courses and Disciplines The Research Fields, Courses and Disciplines (Australian Standard Research Classification) is published by the Australian Bureau of Statistics (ABS catalogue number 1297.0) 1998. ABS data is used with permission from the Australian Bureau of Statistics -> 320000 Medical and Health Sciences -> 320200 Immunology -> 320206 Tumor Immunology :

No further child subject classifications could be found.
  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999) Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 18: 10391-10396. 68   186
Nieda, M., Nicol, A. J., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K. and Juji, T. (1999) Activation of human Valpha24NKT cells by alpha-glycoslceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Human Immunology, 60 1: 10-19. 30   84
Stewart, Trina Jane. (2002). Adoptive immunotherapy studies of HPV16E7-expressing tumours PhD Thesis, School of Medicine, The University of Queensland. 167 2
Sculley, T. B., Buck, M., Gabrielli, B., Parsons, P. G. and Krauer, K. G. (2002) A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus-transformed B-cell lines - A potential therapy for posttransplant lymphoproliferative disease. Transplantation, 73 2: 271-279. 91   10 Cited 10 times in Scopus10
Lin, H, Nieda, M, Rozenkov, V and Nicol, AJ (2006) Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Experimental Hematology, 34 3: 289-295. 57   13 Cited 14 times in Scopus14
Mateo, L. A., Gardner, J., Chen, Q. Y., Schmidt, C., Down, M., Elliott, S. L., Pye, S. J., Firat, H., Lemmonier, F. A., Cebon, J. and Suhrbier, A. (1999) An HLA-A2 polyepitope vaccine for malenoma immunotherapy. Journal of Immunology, 163 7: 4058-4063. 51   60
Juffs, Helen, Fowler, Nina, Saal, Russell, Grimmett, Karen, Beasley, Shannon, O'Sullivan, Brendan, Frazer, Ian H., Gill, Devinder and Thomas, Ranjeny (2004) B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma. Pathology, 36 1: 69-76. 90   4 Cited 4 times in Scopus4
Troy, A. J., Davidson, P. J. T., Atkinson, C. H. and Hart, D. N. J. (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. Journal of Urology, 161 6: 1962-1967. 46   29
Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, Sankaranarayanan, R, Schiller, J, Singer, A, Wright, T, Kinney, W, Meijer, C and Linder, J (2004) Cervical Cancer Control, Priorities and New Directions. International Journal of Cancer, 108 3: 329-333. 50   59 Cited 81 times in Scopus81
Lowy, Douglas R. and Frazer, Ian H. (2003) Chapter 16: Prophylactic Human Papillomavirus Vaccines. Journal of the National Cancer Institute Monographs, 31 : 111-116. 46   Cited 54 times in Scopus54
Mattarollo, Stephen R., Kenna, Tony, Nieda, Mie and Nicol, Andrew J. (2007) Chemotherapy and zoledronate sensitize solid tumour cells to V γ9Vδ2T cell cytotoxicity. Cancer Immunology Immunotherapy, 56 8: 1285-1297. 549   43 Cited 49 times in Scopus49
Koppi, T, Munster, DJ, Brown, L, MacDonald, KPA and Hart, DNJ (2003) CMRF-44 antibody-mediated depletion of activated human dendridic cells: A potential means for improving allograft survival. Transplantation, 75 10: 1723-1730. 24   6 Cited 7 times in Scopus7
Lin, H., Nieda, M., Hutton, J. F., Rozenkov, V. and Nicol, A. J. (2006) Comparative gene expression analysis of NKT cell subpopulations. Journal of Leukocyte Biology, 80 1: 164-173. 21   11 Cited 10 times in Scopus10
Wilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006) Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leukemia & Lymphoma, 47 5: 871-876. 47   4 Cited 6 times in Scopus6
Nicol, A. J., Kikuchi, A., Nieda, M., Hutchins, C., Horley, D., Henry, J. and Durrant, S. T. (1999). Cytotoxic T-Lymphocyte therapy for a patient with chronic myeloid leukaemia. In: , Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 29 Oct, 1999. 14  
Giles, N., Henry, J., Horley, D. and Nicol, A. J. (1999). Dendritic cell (DC) therapy for patients with solid tumors. In: , Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (76). 21 - 27 Oct, 1999. 41  
Hart, D. N. J. and Hill, G. R. (1999) Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma. Immunology and Cell Biology, 77 5: 451-459. 57   23
Peng, J. C., Thomas, R and Dredge, K. (2006) Dendritic cell immunotherapy for melanoma. Reviews on Recent Clinical Trials, 1 2: 87-102. 55   Cited 1 times in Scopus1
Nieda, M, Kikuchi, A, Nicol, A, Koezuka, Y, Ando, Y, Ishihara, S, Lapteva, N, Yabe, T, Tokunaga, K, Tadokoro, K and Juji, T (2001) Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4(+) V alpha 24 natural killer T cells expressing CD40L. Immunology, 102 2: 137-145. 30   12
Yan, Mengyong, Peng, Judy, Abdul Jabbar, Ibtissam A., Liu, Xiaosong, Filgueira, Luis, Frazer, Ian H. and Thomas, Ranjeny (2004) Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology, 324 2: 297-310. 75   32 Cited 34 times in Scopus34
Crough, T, Nieda, M, Morton, J, Bashford, J, Durrant, S and Nicol, AJ (2002) Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia. Journal of Immunotherapy, 25 6: 469-475. 60   4 Cited 6 times in Scopus6
O'Rourke, Michael G. E., Johnson, Maree, Lanagan, Catherine, See, Janet, Yang, Jie, Bell, John R., Slater, Greg J., Kerr, Beverley M., Crowe, Beth, Purdie, David M., Elliott, Suzanne L., Ellem, Kay A. O. and Schmidt, Christopher W. (2003) Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunology Immunotherapy, 52 6: 387-395. 52   108 Cited 110 times in Scopus110
Tisdell, C. (2003) Economic globalisation, liberalisation and Bangladesh: Poverty, labour norms and the environment. South Asia-journal of South Asian Studies, 26 3: 269-282. 34 2 0 Cited 0 times in Scopus0
Brown, R, Murray, A, Pope, B, Sze, DM, Gibson, J, Ho, PJ, Hart, D and Joshua, D (2004) Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta(1) in patients with myeloma. British Journal of Haematology, 125 6: 743-748. 21   25 Cited 28 times in Scopus28
Gandhi, M. K. (2006) Epstein-Barr virus-associated lymphomas. Expert Review of Anti-Infective Therapy, 4 1: 77-89. 24   Cited 16 times in Scopus16
Manders, Peter Matthew (2000). Expression of HPV16E7 as a possible mechanism of escape from a productive anti-E7 immune response PhD Thesis, School of Medicine, The University of Queensland. 49  
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006) Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 7: 2280-2289. 46   56 Cited 64 times in Scopus64
Packer, L. M., Williams, S. J., Callaghan, S., Gotley, D. C. and McGuckin, M. A. (2004) Expression of the cell surface mucin gene family in adenocarcinomas. International Journal of Oncology, 25 4: 1119-1126. 57   26 Cited 25 times in Scopus25
Malcolm, K. M., Gill, J., Leggatt, G. R., Boyd, R., Lambert, P. and Frazer, I. H. (2003) Expression of the HPV16E7 Oncoprotein by Thymic Epithelium is Accompanied by Disrupted T Cell Maturation and a Failure of the Thymus to Involute with Age. Clinical and Developmental Immunology, 10 2-4: 91-103. 38   Cited 3 times in Scopus3
Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M. and Khanna, R. (2003) Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology, 77 9: 5226-5240. 24   157 Cited 166 times in Scopus166
Vuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003) Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 6: 2314-2317. 74   36 Cited 36 times in Scopus36
Firat, Hüseyin, Garcia-Pons, Francisco, Tourdot, Sophie, Pascolo, S., Scardino, A., Garcia, Z., Michel, M., Jack, R. W., Jung, G., Kosmatopoulos, K., Mateo, Luis A., Suhrbier, Andreas, Lemmonier, F. A. and Langlade-Demoyen, P. (1999) H-2 class 1 knockout, HLA-A2.1 transgenic mice: A versatile animal model for preclinical evaluation of antitumour immunotherapeutic strategies. European Journal of Immunology, 29 10: 3112-3121. 27   127 Cited 127 times in Scopus127
Kato, Masato, Khan, Seema, Gonzalez, Nelson, O'Neill, Brian P., McDonald, Kylie J., Cooper, Ben J., Angel, Nicola Z. and Hart, Derek N. J. (2003) Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1. Journal of Biological Chemistry, 278 36: 34035-34041. 49   26 Cited 25 times in Scopus25
Pinto, Ligia A., Castle, Philip E., Roden, Richard B., Harro, Clayton D., Lowy, Douglas R., Schiller, John T., Wallace, Dora, Williams, Marcus, Kopp, William, Frazer, Ian H., Berzofsky, Jay A. and Hildesheim, Allan (2005) HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine, 23 27: 3555-3564. 95   34 Cited 39 times in Scopus39
Hock, B. D., Fearnley, D. B., Boyce, A., McLellan, A. D., Sorg, R. V., Summers, K. L. and Hart, D. N. J. (1999) Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens, 53 4: 320-334. 37   43
Frazer, I. H. (2004). Human Papillomavirus. In Ciro A. de Quadros (Ed.), Vaccines: Preventing Disease & Protecting Health 1 ed. (pp. 140-143) Washington, D.C.: Pan American Health Organisation. 48  
Doan, Tracy, Herd, Karen, Street, Michael, Bryson, Gregory, Fernando, Germain, Lambert, Paul and Tindle, Robert (1999) Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. Journal of Virology, 73 7: 6166-6170. 36   25
Okai, M, Nieda, M, Tazbirkova, A, Horley, D, Kikuchi, A, Durrant, S, Takahashi, T, Boyd, A, Abraham, R, Yagita, H, Juji, T and Nicol, A (2002) Human peripheral blood V alpha 24(+) V beta 11(+) NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sanguinis, 83 3: 250-253. 45   32 Cited 30 times in Scopus30
Nicol, A. J., Kikuchi, A., Nieda, M., Schmidt, C., Giles, N., Horley, D., Henry, J. and Durrant, S. T. (1999). Human Va24+ NKT cells have anti-tumour activity against human melanoma. In: , Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 27 Oct, 1999. 29  
Liu, Xiao Song, Xu, Yan, Hardy, Lani, Khammanivong, Vithagna, Zhao, Weiming M., Fernando, Germain J. P., Leggatt, Graham R. and Frazer, Ian H. (2003) IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host. Journal of Immunology, 171 9: 4765-4772. 78   22 Cited 27 times in Scopus27
Thomas, R, Chambers, M, Boytar, R, Barker, K, Cavanagh, LL, MacFadyen, S, Smithers, M, Jenkins, M and Andersen, J (1999) Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Research, 9 5: 474-481. 153   40
Frazer, I. H., Leippe, D. M., Dunn, L. A., Liem, A., Tindle, R. W., Fernando, G. J. P., Phelps, W. C. and Lambert, P. F. (1995) Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Research, 55 12: 2635-2639. 21 18 33 Cited 34 times in Scopus34
Tindle, R. W. (1999). Immunomodulation of HPV infection and disease. In Robert W. Tindle (Ed.), Vaccines for Human Papillomavirus Infection and Anogenital Disease 1st ed. (pp. 1-12) Texas, USA: R. G. Landes Company. 24  
O'Connor, V. M. (2003) Immunotherapy for HPV associated pre-cancer. Cancer Immunity, 3 S1: 25. 39  
Matsumoto, K., Leggatt, G. R., Zhong, J., Liu, X. S., De Kluyver, R. L., Peters, T., Fernando, G. J. P., Liem, A., Lambert, P. F. and Frazer, I. H. (2004) Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors. Journal of the National Cancer Institute, 96 21: 1611-1619. 154   23 Cited 29 times in Scopus29
McLellan, A. D., Heiser, A. and Hart, D. (1999) Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activities.. Immunology, 98 2: 171-180. 13   18
Stewart, Trina J., Smyth, Mark J., Fernando, Germain J. P., Frazer, Ian H. and Leggatt, Graham R. (2003) Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells. Cancer Research, 63 12: 3058-3060. 51   37 Cited 36 times in Scopus36
Barnard, P. (2000). Inhibition of Interferon signalling by human papillomavirus PhD Thesis, School of Medicine, The University of Queensland. 73  
Stewart, Trina J., Drane, Debbie, Malliaros, Jim, Elmer, Heidi, Malcolm, Karen M., Cox, John C., Edwards, Stirling J., Frazer, Ian H. and Fernando, Germain J. P. (2004) ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines. Vaccine, 22 27-28: 3738-3743. 111   22 Cited 26 times in Scopus26
Frazer, I. H. (2004) Is vaccine therapy the future in cancer prevention?. Expert Opinion on Pharmacotherapy, 5 12: 2427-2434. 38   0 Cited 0 times in Scopus0

Page 1 of 2

Result Pages:    1 2  next › last »